主页文献库搜索
Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppresso...

Harms(Paul W),Hovelson(Daniel H),Cani(Andi... Hum Pathol 2016-08-22

...PIK3CA-activating mutation reported in 1 case. We analyzed 5 porocarcinomas by next-generation sequencing using the DNA ...

Genetic Investigation of Uterine Carcinosarcoma: Case Report and Cohort Analy...

Hembree(Timothy N),Teer(Jamie K),Hakam(Ard... Cancer Control 2016-10-31

...PIK3CA, CTNNB1, PTEN, FBXW7, TP53, and ERBB2; of these, TP53 was the most frequently mutated gene (6/9). In addition, AR...

New insights on PI3K/AKT pathway alterations and clinical outcomes in breast ...

Yang(Sherry X),Polley(Eric),Lipkowitz(Stan... Cancer Treat Rev 2016-08-19

...PIK3CA mutations and AKT activation by phosphorylation (pAKT) are often detected in many cancers and especially at high ...

Genetics of Bladder Malignant Tumors in Childhood.

Zangari(Andrea),Zaini(Johan),Gulìa(Caterin... Curr Genomics 2016-03-25

...PIK3CA, CTNNB1, FBXW7, IGF1R, PDGFRA, ERBB2/4, MET, BCOR. Malignant rhabdoid tumor (MRT) usually shows SMARCB1/INI1 alte...

Initiation of a formalized precision medicine program in gynecologic oncology...

Gunderson(Camille C),Rowland(Michelle R),W... Gynecol Oncol 2016-08-16

...PIK3CA (27%) were the most frequently noted mutations; however, molecular profiling resulted in identification of few ac...

Tumor mutational analysis of GOG248, a phase II study of temsirolimus or tems...

Myers(Andrea P),Filiaci(Virginia L),Zhang(... Gynecol Oncol 2016-08-16

...PIK3CA, PIK3R1, KRAS, CTNNB1, AKT1, TSC1, TSC2, NF1, FBXW7) were explored.,Sequencing data was obtained from tumors of 5...

A SNaPshot of potentially personalized care: Molecular diagnostics in gynecol...

Penson(R T),Sales(E),Sullivan(L),Borger(D ... Gynecol Oncol 2016-08-16

...PIK3CA, PTEN, TP53).,Between 5/17/10 and 8/8/13, 249 pts consented to SNaPshot analysis. Median age 60 (29-84) yrs. Tumo...

Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhi...

Leroy(Cedric),Ramos(Pedro),Cornille(Karen)... Breast Cancer Res 2016-10-07

...PIK3CA mutant breast cancers. This provides a rationale for the combined targeting of p110α with IGF1R or p110β in patie...

Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mo...

Elwood(Peter C),Morgan(Gareth),Pickering(J... PLoS One 2016-08-25

...PIK3CA was present in about 20% of patients, and appeared to explain most of the reduction in colon cancer mortality by ...

Identification of potential therapeutic targets by molecular profiling of 628...

Jones(Nathaniel L),Xiu(Joanne),Reddy(Sande... Gynecol Oncol 2016-02-01

Therapeutic options are limited for uterine serous carcinoma (USC). TP53, PIK3CA, FBXW7, and ERBB mutations, as well as ...

上一页 117 118 119 120 121 122 123 124 125 下一页 121 / 共 353

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com